weight loss program with semaglutide glp-1 ozempic in laguna beach Best Medical Clinics Orange County CA Patient transformation story, New Hope

Retatrutide belongs to a new class of drugs called triple agonists

Clinical trials of semaglutide and dulaglutide have demonstrated A1c reductions of 1.0% to 1.5% or more from baseline after three to six months of treatment

These shifts were often significant enough to suggest clinical relevance in the context of type 2 diabetes management

Patients with metabolic syndrome are four times more likely to develop dementia, while the patient population has elevated levels of pro-inflammatory markers such as C-reactive protein and interleukin IL-6 [37]

Does my primary care doctor know I'm considering GLP-1 medications and support this approach